Utilities and disutilities for type 2 diabetes treatment-related attributes

@article{Matza2007UtilitiesAD,
  title={Utilities and disutilities for type 2 diabetes treatment-related attributes},
  author={Louis S. Matza and Kristina Secnik Boye and Nicole R. Yurgin and Jessica Brewster-Jordan and Sally Mannix and Jodi M. Shorr and Beth Louise Barber},
  journal={Quality of Life Research},
  year={2007},
  volume={16},
  pages={1251-1265}
}
Although cost-utility analyses are frequently used to estimate treatment outcomes for type 2 diabetes, utilities are not available for key medication-related attributes. The purpose of this study was to identify the utility or disutility of diabetes medication-related attributes (weight change, gastrointestinal side effects, fear of hypoglycemia) that may influence patient preference. Patients with type 2 diabetes in Scotland and England completed standard gamble (SG) interviews to assess… CONTINUE READING
BETA

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 56 CITATIONS

FILTER CITATIONS BY YEAR

2008
2018

CITATION STATISTICS

  • 3 Highly Influenced Citations

  • Averaged 4 Citations per year over the last 3 years

  • 11% Increase in citations per year in 2018 over 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 79 REFERENCES

Comparison of four preference measures

  • Stavem, K. . Quality of life in epilepsy
  • Epilepsy Research, 29(3), 201–209. 1264 Qual…
  • 2007

Assessment report: The clinical and cost-effectiveness of longacting insulin analogue, insulin

  • E. Warren, E. Weatherley-Jones, J Chilcott
  • glargine. [Online]. Available at: http://www.nice…
  • 2006
1 Excerpt

Utility assessment

  • J. Mauskopf
  • 2006

Similar Papers

Loading similar papers…